Lipella Pharmaceuticals Inc. (LIPO)
OTCMKTS · Delayed Price · Currency is USD
0.1551
0.00 (0.00%)
At close: Feb 18, 2026
Lipella Pharmaceuticals Market Cap
Lipella Pharmaceuticals has a market cap or net worth of $716.69 thousand as of February 20, 2026. Its market cap has decreased by -79.20% in one year.
Market Cap
716.69K
Enterprise Value
-875.00K
Revenue
389.78K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.16
Market Cap Chart
Since December 20, 2022, Lipella Pharmaceuticals's market cap has decreased from 27.05M to 716.69K, a decrease of -97.35%. That is a compound annual growth rate of -68.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 18, 2026 | 716.69K | -13.83% |
| Dec 31, 2025 | 831.75K | -77.44% |
| Dec 31, 2024 | 3.69M | -37.72% |
| Dec 29, 2023 | 5.92M | -67.07% |
| Dec 30, 2022 | 17.98M | -33.55% |
| Dec 20, 2022 | 27.05M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EV Biologics | 905.15K |
| Sorrento Therapeutics | 869.94K |
| Eastgate Biotech | 846.29K |
| Protagenic Therapeutics | 809.72K |
| SQZ Biotechnologies Company | 707.79K |
| Aibotics | 666.21K |
| Bio-Path Holdings | 644.18K |
| Helix BioMedix | 606.71K |